Navigation Links
Infection biology: How Legionella subverts to survive
Date:7/18/2013

Bacteria of the genus Legionella have evolved a sophisticated system to replicate in the phagocytic cells of their hosts. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have now identified a novel component of this system.

In humans, Legionella is responsible for the so-called Legionnaires' disease, a form of bacterial pneumonia that is often lethal. The bacteria can also cause Pontiac fever, a flu-like condition characterized by coughing and vomiting. Most Legionella-associated illnesses in humans are caused by Legionella pneumophila.

These microorganisms are found in soil, lakes and rivers, and can enter our water supply via the groundwater. The greatest risk of human infection arises when the bacteria colonize air-conditioning ducts or piping used to transport warm water. Persons can be infected when they inhale contaminated aerosols in the shower, for instance.

The research group led by Hubert Hilbi, Professor of Medical Microbiology at LMU, studies how these intracellular parasites survive and replicate in phagocytic cells of their eukaryotic hosts or in the environment. For instance, the pathogen can grow and proliferate in the amoeba Dictyostelium, which normally preys on soil bacteria, engulfing and digesting them. But Legionella turns the tables, resists degradation and continues to grow in the amoeba until it is so full of bacteria that it bursts.

Legionella sabotages the immune system

When L. pneumophila cells infect the human lung, essentially the same thing happens. The bacteria are taken up by white blood cells called macrophages, which normally clear bacterial pathogens from the circulation. But instead of being consumed, the bacteria replicate in the macrophages and ultimately destroy them. Robbed of its first line of defense, the immune system has difficulty coping with the infection, and a life-threatening pneumonia may develop.

The biochemical processes that enable the parasites to outwit their temporary hosts are highly complex. Thus, L. pneumophila secretes around 300 proteins into the infected cell, which is forced to redirect its resources for the bacterium's benefit.

Hilbi and his colleagues have now characterized one of these proteins and describe its mode of action for the first time. This factor, called RidL, disrupts an intracellular transport system that is necessary for the elimination of ingested bacteria. RidL binds to the so-called retromer complex, which is needed for the continued recycling of receptors, which deliver degradative enzymes to phagosomes containing bacteria destined for digestion. "We demonstrate that Legionella blocks the retromer-dependent transport route, thus promoting its own survival in the cell," Hilbi explains. This function is unique. "Proteins that act in this way are otherwise unknown in the bacterial world, and are not found in higher organisms either," he adds.


'/>"/>

Contact: Luise Dirscherl
dirscherl@lmu.de
49-892-180-2706
Ludwig-Maximilians-Universitt Mnchen
Source:Eurekalert

Related biology news :

1. Queens scientists seek vaccine for Pseudomonas infection
2. BPA could affect reproductive capabilities, cause infection of the uterus
3. To drive infections, a hijacking virus mimics a cells signaling system
4. Women & Infants participating in study of treatment of common viral infection in pregnancy
5. Bartonella infection associated with rheumatoid illnesses in humans
6. Salmonella infection, but not as we know it
7. Vitamin D supplements may protect against viral infections during the winter
8. New data suggests HIV superinfection rate comparable to initial HIV infection
9. How alert hospital employees improved hospitals MSRA infection rate
10. Childhood virus infection linked to prolonged seizures with fever
11. Infection biology: The elusive third factor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug ... Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( ... expected to deliver therapeutic levels of olanzapine for a period of 3 months., “We ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... 2017 Symic Bio, a biopharmaceutical company focused ... of therapeutics, announced today the completion of enrollment for ... disease. The trial will evaluate the safety and efficacy ... reduction of restenosis following angioplasty. "We,re ... SB-030," said Nathan Bachtell , M.D., Chief Medical ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: